Douglas Earl Martin - Insider Non-Derivative Transactions at Allogene Therapeutics, Inc. (ALLO) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Aug 21, 2024, Douglas Earl Martin's relationship to Allogene Therapeutics, Inc. (ALLO) is Officer (SVP, General Counsel), and currently has 449,324 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other ALLO insiders.
Data Source: SEC.
Douglas Earl Martin - Insider Non-Derivative Transactions of ALLO Common Stock
Douglas Earl Martin - Insider Non-Derivative Transactions at ALLO
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Aug 22, 2024 | F -- (Common Stock) | 28310 | 2.79 | 449324 |
| Jan 26, 2024 | Acquisition -- (Common Stock) | 41800 | 0 | 477634 |
| Aug 15, 2023 | Acquisition -- (Common Stock) | 108958 | 0 | 108958 |
| Aug 15, 2023 | Acquisition -- (Common Stock) | 326876 | 0 | 435834 |